The Surviving Sepsis Campaign Bundle: 2018 update

Introduction The “sepsis bundle” has been central to the implementation of the Surviving Sepsis Campaign (SSC) from the first publication of its evidence-based guidelines in 2004 through subsequent editions [1–6]. Developed separately from the guidelines publication by the SSC, the bundles have been the cornerstone of sepsis quality improvement since 2005 [7–11]. As noted when they were introduced, the bundle elements were designed to be updated as indicated by new evidence and have evolved accordingly. In response to the publication of “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016” [12, 13], a revised “hour-1 bundle” has been developed and is presented below (Fig. 1). The compelling nature of the evidence in the literature, which has demonstrated an association between compliance with bundles and improved survival in patients with sepsis and septic shock, led to the adoption of the SSC measures by the National Quality Forum (NQF) and subsequently both by the New York State (NYS) Department of Health [14] and the Centers for Medicare and Medicaid Services (CMS) [15] in the USA for mandated public reporting. The important relationship between the bundles and survival was confirmed in a publication from this NYS initiative [16]. Paramount in the management of patients with sepsis is the concept that sepsis is a medical emergency. As with polytrauma, acute myocardial infarction, and stroke, early identification and appropriate immediate management in the initial hours after development of sepsis improves outcomes [7–11, 14, 16–21]. The guidelines state that these patients need urgent assessment and treatment, including initial fluid resuscitation while pursuing source control, obtaining further laboratory results, and attaining more precise measurements of hemodynamic status. A guiding principle is that these complex patients need a detailed initial assessment and then ongoing re-evaluation of their response to treatment. The elements of the 2018 bundle, intended to be initiated within the first hour, are listed in Table 1 and presented in the following. Consistent with previous iterations of the SSC sepsis bundles, “time zero” or “time of presentation” is defined as the time of triage in the emergency department or, if referred from another care location, from the earliest chart annotation consistent with all elements of sepsis (formerly severe sepsis) or septic shock ascertained through chart review. Because this new bundle is based on the 2016 Guidelines publication, the guidelines themselves should be referred to for further discussion and evidence related to each element and to sepsis management as a whole.

[1]  Y. Shimada,et al.  Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis , 1982, Critical care medicine.

[2]  P. Bollaert,et al.  Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. , 1990, Chest.

[3]  L. Papazian,et al.  Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? , 1992, Chest.

[4]  P Leppard,et al.  Epinephrine as an inotropic agent in septic shock: A dose‐profile analysis , 1993, Critical care medicine.

[5]  N. Day,et al.  The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection , 1996, The Lancet.

[6]  P. Nabet,et al.  Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study , 1997, Intensive Care Medicine.

[7]  X Viviand,et al.  Effect of norepinephrine on the outcome of septic shock , 2000, Critical care medicine.

[8]  J. Kanegaye,et al.  Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. , 2001, Pediatrics.

[9]  Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. , 2002, Acta pharmacologica Sinica.

[10]  J. Vincent,et al.  Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? , 2003, Critical care medicine.

[11]  P. Pronovost,et al.  Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. , 2004, Critical care medicine.

[12]  Herwig Gerlach,et al.  Reply to Zandstra and van der Voort , 2004, Intensive Care Medicine.

[13]  Mitchell M. Levy,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[14]  F. Kapadia,et al.  Adrenaline in treatment of septic shock: Effects on haemodynamics and oxygen transport , 2005, Intensive Care Medicine.

[15]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[16]  B. Levy Lactate and shock state: the metabolic view , 2006, Current opinion in critical care.

[17]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[18]  Joyce Polessi,et al.  The impact of each action in the Surviving Sepsis Campaign measures on hospital mortality of patients with severe sepsis/septic shock Impacto de cada ação dos pacotes da Surviving Sepsis Campaign na mortalidade hospitalar de pacientes portadores de sepse grave/choque séptico , 2008 .

[19]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[20]  J. Bakker,et al.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. , 2010, American journal of respiratory and critical care medicine.

[21]  Richard Beale,et al.  The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis* , 2010, Critical care medicine.

[22]  Armando Teixeira-Pinto,et al.  ResearchReducing mortality in severe sepsis with the implementation of a core 6-hour bundle : results from the Portuguese community-acquired sepsis study ( SACiUCI study ) , 2010 .

[23]  Alan E. Jones,et al.  Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. , 2010, JAMA.

[24]  Huan-huan Tian,et al.  [The effect of early goal lactate clearance rate on the outcome of septic shock patients with severe pneumonia]. , 2012, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.

[25]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[26]  Zhenjie Hu,et al.  [Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis]. , 2013, Zhonghua wei zhong bing ji jiu yi xue.

[27]  David N. Williams,et al.  Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  S. Lemeshow,et al.  Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study , 2014, Intensive Care Medicine.

[29]  M. Levy,et al.  Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.

[30]  P. Marik,et al.  Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. , 2014, Anaesthesiology intensive therapy.

[31]  Cheng Cheng Tan,et al.  The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) , 2015, Intensive Care Medicine.

[32]  Mitchell M. Levy,et al.  Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion: Results From the Surviving Sepsis Campaign Database* , 2015, Critical care medicine.

[33]  E. Adrario,et al.  Effect of Performance Improvement Programs on Compliance with Sepsis Bundles and Mortality: A Systematic Review and Meta-Analysis of Observational Studies , 2015, PloS one.

[34]  J. Himmelfarb,et al.  Volume Overload: Prevalence, Risk Factors, and Functional Outcome in Survivors of Septic Shock. , 2015, Annals of the American Thoracic Society.

[35]  J. Vincent,et al.  A positive fluid balance is an independent prognostic factor in patients with sepsis , 2015, Critical Care.

[36]  G. Cai,et al.  [Efficacies of fluid resuscitation as guided by lactate clearance rate and central venous oxygen saturation in patients with septic shock]. , 2015, Zhonghua yi xue za zhi.

[37]  F. Machado,et al.  Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. , 2015, Journal of critical care.

[38]  Anand Kumar Systematic Bias in Meta-Analyses of Time to Antimicrobial in Sepsis Studies. , 2016, Critical care medicine.

[39]  G. Escobar,et al.  Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and Intermediate Lactate Values. , 2016, American journal of respiratory and critical care medicine.

[40]  Ori Galante,et al.  Positive fluid balance as a major predictor of clinical outcome of patients with sepsis/septic shock after ICU discharge. , 2016, The American journal of emergency medicine.

[41]  Sangeeta Mehta,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[42]  M. Doerfler,et al.  Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts , 2017, Critical care medicine.

[43]  S. Lemeshow,et al.  Time to Treatment and Mortality during Mandated Emergency Care for Sepsis , 2017, The New England journal of medicine.